🌟 Navigating AI in Medication Guidance: A Safety Priority 🌟
Public-facing AI assistants are transforming how patients receive medication guidance, often before they consult healthcare professionals. 📈 However, while the spotlight has been on incorrect AI outputs, a critical issue looms: the omission of vital safety information from approved product labels.
Key Insights:
- Post-market risk: AI-mediated omissions of contraindications pose serious safety risks that pharmaceutical companies currently overlook.
- Evidentiary tools: Using Reasoning Claim Tokens (RCTs) allows us to detect and document these omissions without delving into AI model internals.
- Pharmacovigilance: This analysis relates omission risks to existing pharmacovigilance practices and highlights key governance implications like detectability and predictability.
As AI continues to evolve, ensuring patient safety must remain a priority. 💡
🔗 Join the conversation! Share your thoughts and let’s raise awareness about AI safety in healthcare. #AI #Pharmacovigilance #PatientSafety
